4.5 Review

Carbohydrate clearance receptors in transfusion medicine

Journal

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
Volume 1820, Issue 11, Pages 1797-1808

Publisher

ELSEVIER
DOI: 10.1016/j.bbagen.2012.07.008

Keywords

Lectins; Carbohydrate; Sialic acid; Recombinant proteins; Platelet transfusion; Platelet storage

Funding

  1. Danish Medical Research Council
  2. Blood Donors Research Fund
  3. Novo Nordisk Foundation
  4. Danish Cancer Research Foundation
  5. Agnes and Poul Friis Foundation
  6. University of Copenhagen
  7. Danish National Research Foundation

Ask authors/readers for more resources

Background: Complex carbohydrates play important functions for circulation of proteins and cells. They provide protective shields and refraction from non-specific interactions with negative charges from sialic acids to enhance circulatory half-life. For recombinant protein therapeutics carbohydrates are especially important to enhance size and reduce glomerular filtration loss. Carbohydrates are, however, also ligands for a large number of carbohydrate-binding lectins exposed to the circulatory system that serve as scavenger receptors for the innate immune system, or have more specific roles in targeting of glycoproteins and cells. Scope of review: Here we provide an overview of the common lectin receptors that play roles for circulating glycoproteins and cells, and present a discussion of ways to engineer glycosylation of recombinant biologics and cells to improve therapeutic effects. Major conclusions: While the pharmaceutical industry has learned how to exploit carbohydrates to improve pharmacokinetic properties of recombinant therapeutics, our understanding of how to improve cell-based therapies by manipulation of complex carbohydrates is still at its infancy. Progress with the latter has recently been achieved with cold-stored platelets, where exposure of uncapped glycans lead to rapid clearance from circulation by several lectin-mediated pathways. General significance: Understanding lectin-mediated clearance pathways is essential for progress in development of biological pharmaceuticals. (C) 2012 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available